Search

Displaying results 7401 - 7410 of 10000 in total
  1. Drug

    Gisadenafil

    go.drugbank.com/drugs/DB11902
    Investigational

    Gisadenafil has been investigated for the treatment of Prostatic Hyperplasia.

  2. Drug

    Napabucasin

    go.drugbank.com/drugs/DB12155
    Investigational

    Napabucasin has been investigated for the treatment of Colorectal Carcinoma.

  3. Drug

    Puerarin

    go.drugbank.com/drugs/DB12290
    Investigational

    Puerarin has been investigated for the treatment of Alcohol Abuse.

  4. Drug

    Piclozotan

    go.drugbank.com/drugs/DB12361
    Investigational

    Piclozotan has been investigated for the treatment of Parkinson's Disease.

  5. Drug

    Glyceryl Trierucate

    go.drugbank.com/drugs/DB12528
    Investigational

    Glyceryl Trierucate has been investigated for the treatment of Adrenoleukodystrophy.

  6. Drug

    Cerlapirdine

    go.drugbank.com/drugs/DB12229
    Investigational

    Cerlapirdine has been investigated for the treatment of Alzheimer Disease.

  7. Drug

    Polyacrylamide (crosslinked; 2 mole percent bisacrylamide)

    go.drugbank.com/drugs/DB14771
    Investigational

    Polyacrylamide (crosslinked; 2 mole percent bisacrylamide) is under investigation in clinical trial NCT00629083 (Bulking Agents for the Treatment of Stress Urinary Incontinence in Females).

  8. Drug

    ALMB-0168

    go.drugbank.com/drugs/DB16926
    Investigational

    ALMB-0168 is a humanized connexin 43 (Cx43) monoclonal antibody being investigated for osteosarcoma.

  9. Drug

    Rotigaptide

    go.drugbank.com/drugs/DB13067
    Investigational

    Rotigaptide is under investigation for the basic science of Heart Disease and Vascular Disease.

  10. Drug

    Reloxiliase

    go.drugbank.com/drugs/DB17653
    Experimental

    Reloxiliase is a first-in-class, oral crystalline formulation of the oxalate-specific, microbial enzyme oxalate decarboxylase. It is being investigated for the treatment of hyperoxaluria.[A258823]